Opdualag 240-80 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB26FNNKZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,347
Award facts
- Contract value 100% obligated
- $39,346.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $39,346.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Opdualag 240-80 mg/20 ml vials. The contract is non-set-aside and represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 7, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999,999,999.00 global pharmaceutical support vehicle valued through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems through its extensive portfolio of pharmaceutical products and medical supplies. The company's federal contracting demonstrates significant capability in supplying specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. As a child contract under the DLA Troop Support Medical prime IDC, this delivery order supports the agency's medical supply chain operations for Defense Health Agency customers and other government healthcare systems. The firm fixed-price structure and competitive award status reflect AmerisourceBergen's ability to meet federal procurement requirements while serving as a key component of DLA's pharmaceutical procurement strategy.
Quick answers
Who was awarded contract SPE2DB26FNNKZ?
SPE2DB26FNNKZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 17, 2025.
How much is contract SPE2DB26FNNKZ worth?
The government has obligated $39,347 on SPE2DB26FNNKZ.
Is contract SPE2DB26FNNKZ an order under another contract?
Yes. SPE2DB26FNNKZ is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB26FNNKZ competed?
The extent of competition for SPE2DB26FNNKZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award